ListedMainboardPharmaceuticals & DrugsANTHEM
Anthem Biosciences IPO
Anthem Biosciences IPO is a mainboard IPO raising ₹3,395 Cr at ₹540 – ₹570 a share. It listed on 21 Jul 2025 at ₹723, +26.9% against its issue price of ₹570, and trades at ₹941 today (+65.0% since issue). It was subscribed 64× in total.
₹570
Issue price
₹941
Price now
+65.0%
Since issue price
21 Jul 2025
Listed on
64×Subscribed (final) · all exchanges
63.9 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Lead managers, and how their past issues have done
Median return since issue price across every IPO we hold this bank on. Not a forecast for this issue — a record.
| Lead manager | IPOs we hold them on | Of which we can price | Median return since issue |
|---|---|---|---|
| JM Financial Limited | 109 | 102 | +29.1% |
| Citigroup Global Markets India Private Limited | 34 | 33 | +28.4% |
| J.P. Morgan India Private Limited | 31 | 30 | +30.5% |
| Nomura Financial Advisory | 27 | 27 | +28.4% |
| Securities (India) Private Limited | 27 | 27 | +30.6% |
A bank appears on an issue we can price only when the company is matched to our price history, so the two counts differ. See the full league table →
Registrar
Contact them about allotment, refunds or unblocking your application amount — not the company, and not the exchange.
NameKFin Technologies Limited
ContactM. Murali Krishna
Emailanthem.ipo@kfintech.com
Phone +91 40 6716 2222
Websitehttps://www.kfintech.com/ ↗